logo

AYTU

Aytu BioPharma·NASDAQ
--
--(--)
--
--(--)
7.27 / 10
Outperform

Fund-flow analysis is encouraging, with a score of 7.61/10 and overall positive trend. Block, Small, Large, and Extra-large orders show net inflows (ratios 0.52-0.55), while Medium orders are slightly negative (0.47). This indicates institutional and retail interest, supporting the idea that dip-buyers are active. Coupled with a unanimous Strong Buy analyst rating from Ascendiant Capital, the fund-flow data reinforce a bullish sentiment that could help stabilize the stock once technicals improve.

FundamentalSentiment(7.27)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

100%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2025-12-10
InstitutionAscendiant Capital
Times predicted3
Historical Win Rate100.0%
What is the analyst consensus for AYTU?
  • AYTU holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.27/10 (Outperform).